SUPN Supernus Pharmaceuticals Inc

NASDAQ
$41.28

Supernus Pharmaceuticals Inc (SUPN) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with SUPN's own trailing one-year pace, with 49% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 0 sellers in the last 90 days
Insiders buying
0
0 transactions
Insiders selling
8
30 transactions
Purchases
$0
0 shares
Sales
$19.7M
393,991 shares
Net activity
-$19.7M
purchases less sales

How much of that selling was preplanned? 49% planned / 51% discretionary

10b5-1 plan sales $9.7M 15 transactions · 191,725 shares
Discretionary sales $10.0M 15 transactions · 202,266 shares

Largest single sale: $3.0M.

Where they traded

Buy Sell Dot area is proportional to transaction value.

No open-market insider purchase on record.

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Bhatt Padmanabh P. 2 fills Sr. VP of IP, CSO Sell 10b5-1 7,250 $49.60 $359.6K 17,456 −29.3% of holding
Bhatt Padmanabh P. 2 fills Sr. VP of IP, CSO Sell 10b5-1 50,000 $50.30 $2.5M 39,334 −56% of holding
Bhatt Padmanabh P. 2 fills Sr. VP of IP, CSO Sell 10b5-1 50,000 $50.28 $2.5M 32,930 −60.3% of holding
Khattar Jack A. 3 fills President, CEO Sell 10b5-1 35,000 $50.37 $1.8M 968,962 −3.5% of holding
Hudson Frederick M. Director Sell 5,369 $50.61 $271.7K 60,413 −8.2% of holding
Horich William Todd SVP, Commercial Operations Sell 4,439 $55.00 $244.1K None left
Horich William Todd SVP, Commercial Operations Sell 4,438 $54.00 $239.7K 4,439 −50% of holding
Mottola Frank SVP, Chief Tech. Ops. Officer Sell 1,623 $53.65 $87.1K 18,440 −8.1% of holding
GEMAYEL GEORGES Director Sell 8,787 $53.00 $465.7K 27,277 −24.4% of holding
GEMAYEL GEORGES Director Sell 10,000 $53.71 $537.1K 28,159 −26.2% of holding
Sensenig Bethany 2 fills Director Sell 10b5-1 4,475 $51.01 $228.3K 3,258 −57.9% of holding
Mottola Frank 2 fills SVP, Chief Tech. Ops. Officer Sell 10b5-1 20,000 $50.41 $1.0M 15,496 −56.3% of holding
Bhatt Padmanabh P. Sr. VP of IP, CSO Sell 710 $44.44 $31.6K 14,508 −4.7% of holding
Khattar Jack A. 2 fills President, CEO Sell 59,900 $50.57 $3.0M 1,208,107 −4.7% of holding
NEWHALL CHARLES W III 2 fills Director Sell 10b5-1 25,000 $50.77 $1.3M 105,844 −19.1% of holding
Khattar Jack A. President, CEO Sell 1,904 $48.06 $91.5K 1,161,233 −0.2% of holding
Khattar Jack A. President, CEO Sell 40,173 $48.07 $1.9M 1,160,870 −3.3% of holding
Khattar Jack A. President, CEO Sell 8,588 $48.25 $414.4K 1,147,258 −0.7% of holding
Khattar Jack A. President, CEO Sell 10,235 $48.02 $491.5K 1,144,336 −0.9% of holding
Khattar Jack A. President, CEO Sell 29,513 $47.23 $1.4M 1,140,883 −2.5% of holding
Khattar Jack A. President, CEO Sell 16,587 $47.02 $779.9K 1,122,456 −1.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.